Diuretic use in incident ESKD: Are we out of the loop?
作者信息
Wang Ke, Bansal Nisha
机构信息
Kidney Research Institute, Division of Nephrology, University of Washington, Seattle, Washington.
出版信息
Clin J Am Soc Nephrol. 2019 Jan 7;14(1):13-15. doi: 10.2215/CJN.13361118. Epub 2018 Dec 19.
Abstract
摘要
相似文献
1
Diuretic use in incident ESKD: Are we out of the loop?新发终末期肾病中利尿剂的使用：我们是否被排除在外了？
Clin J Am Soc Nephrol. 2019 Jan 7;14(1):13-15. doi: 10.2215/CJN.13361118. Epub 2018 Dec 19.
2
Measures of Loop Diuretic Efficiency and Prognosis in Chronic Kidney Disease.在慢性肾脏病中测量袢利尿剂的效率和预后。
Cardiorenal Med. 2020;10(6):402-414. doi: 10.1159/000509741. Epub 2020 Oct 29.
3
In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.在伴有明显液体潴留的慢性心力衰竭中，静脉注射大剂量袢利尿剂是肾功能恶化的一个预测指标，尤其是在左心室收缩功能正常或仅轻度受损的心力衰竭患者中。
Minerva Cardioangiol. 2011 Dec;59(6):543-54. Epub 2011 Feb 18.
4
[Pharmacological Properties of Loop Diuretics and Their Clinical Effects].[袢利尿剂的药理特性及其临床效果]
Kardiologiia. 2018 Jan(1):72-83. doi: 10.18087/cardio.2018.1.10084.
5
[Diuretic therapy in acute heart failure].[急性心力衰竭的利尿治疗]
Med Clin (Barc). 2014 Mar;142 Suppl 1:36-41. doi: 10.1016/S0025-7753(14)70081-8.
6
Outcomes Associated With a Strategy of Adjuvant Metolazone or High-Dose Loop Diuretics in Acute Decompensated Heart Failure: A Propensity Analysis.在急性失代偿性心力衰竭中辅助使用美托拉宗或高剂量袢利尿剂的策略相关结局：倾向评分分析。
J Am Heart Assoc. 2018 Sep 18;7(18):e009149. doi: 10.1161/JAHA.118.009149.
7
Association of Continuation of Loop Diuretics at Hemodialysis Initiation with Clinical Outcomes.起始血液透析时继续使用噻嗪类利尿剂与临床结局的关联。
Clin J Am Soc Nephrol. 2019 Jan 7;14(1):95-102. doi: 10.2215/CJN.05080418. Epub 2018 Dec 19.
8
Combination of loop diuretics with thiazide-type diuretics in heart failure.心力衰竭中袢利尿剂与噻嗪类利尿剂的联合应用。
J Am Coll Cardiol. 2010 Nov 2;56(19):1527-34. doi: 10.1016/j.jacc.2010.06.034.
9
Loop diuretics, renal function and clinical outcome in patients with heart failure and reduced ejection fraction.射血分数降低的心力衰竭患者中袢利尿剂、肾功能与临床结局
Eur J Heart Fail. 2016 Mar;18(3):328-36. doi: 10.1002/ejhf.462. Epub 2015 Dec 23.
10
A perspective on diuretic resistance in chronic congestive heart failure.慢性充血性心力衰竭中利尿剂抵抗的观点
Ther Adv Cardiovasc Dis. 2017 Oct;11(10):271-278. doi: 10.1177/1753944717718717. Epub 2017 Jul 20.
引用本文的文献
1
Diuretics in patients with chronic kidney disease.慢性肾脏病患者的利尿剂
Nat Rev Nephrol. 2025 Apr;21(4):264-278. doi: 10.1038/s41581-024-00918-x. Epub 2025 Jan 7.
2
Diuretics and mortality reduction in incident dialysis patients: a two-year observational study.利尿剂在新进入透析患者中降低死亡率的作用：一项为期两年的观察性研究。
Sci Rep. 2024 Nov 10;14(1):27447. doi: 10.1038/s41598-024-65643-8.
3
Comparative effectiveness of an individualized model of hemodialysis vs conventional hemodialysis: a study protocol for a multicenter randomized controlled trial (the TwoPlus trial).个体化血液透析模型与常规血液透析的比较效果：一项多中心随机对照试验（TwoPlus 试验）的研究方案。
Trials. 2024 Jun 28;25(1):424. doi: 10.1186/s13063-024-08281-9.
Zotero 插件